If you liked this article you might like

Prothena Raises $155.3M to Bring Anti-Organ Failure Drug to Market
Biotech Premarket Movers: Karyopharm, Lexicon, Prothena
Prothena (PRTA) Is Today's Perilous Reversal Stock
Prothena (PRTA) Flagged As Strong On High Volume